Tereza Kasaeva
Biographic Data
| ID | 9068542 |
|---|---|
| NAME | Tereza Kasaeva |
| GIVEN NAMES | Tereza |
| FAMILY NAME | Kasaeva |
| SIGNATURE | KASAEVA T |
| AFFILIATIONS | World Health Organization |
| ORCID | 0000-0002-3986-1460 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Aligning action across major infectious diseases in a dynamic global health landscape
In July 2025, WHO merged its Department of HIV, Viral Hepatitis and STIs with the Global Programme on Tuberculosis and Lung Health, creating a new structure -the Department of HIV, TB, Hepatitis and STIs.Although this decision was driven by unprecedented financial shortfalls, there is a strong underlying rationale, creating opportunities to identify synergies and efficiencies without losing the gains made in recent years.HIV, TB, Hepatitis and ST…
Tuberculosis at the crossroads
Tuberculosis (TB) remains the world’s deadliest infectious disease kiler, affecting the most vulnerable, including refugees and migrants. Their vulnerability is intensified by structural and social barriers that hinder diagnosis and treatment and restrict healthcare access. To put a spotlight on this issue, the WHO in collaboration with the Qatar Foundation launched a technical report on innovative solutions for TB elimination among refugees and …
WHO target product profile for TB detection at peripheral settings
In 2014, the World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal criteria to address high-priority TB diagnostic needs. Since then, the TB community’s needs have evolved; there has been a surge in new and innovative platforms suggesting use of alternative non-invasive specimens for TB diagnosis. This updated TPP used evidence-based modelling to guide the decision-making process for specific …
Achieving universal access to rapid tuberculosis diagnostics
No prominent works on this page.
Achieving universal access to rapid tuberculosis diagnostics
Tuberculosis at the crossroads
Tuberculosis (TB) remains the world’s deadliest infectious disease kiler, affecting the most vulnerable, including refugees and migrants. Their vulnerability is intensified by structural and social barriers that hinder diagnosis and treatment and restrict healthcare access. To put a spotlight on this issue, the WHO in collaboration with the Qatar Foundation launched a technical report on innovative solutions for TB elimination among refugees and …
WHO target product profile for TB detection at peripheral settings
In 2014, the World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal criteria to address high-priority TB diagnostic needs. Since then, the TB community’s needs have evolved; there has been a surge in new and innovative platforms suggesting use of alternative non-invasive specimens for TB diagnosis. This updated TPP used evidence-based modelling to guide the decision-making process for specific …
Aligning action across major infectious diseases in a dynamic global health landscape
In July 2025, WHO merged its Department of HIV, Viral Hepatitis and STIs with the Global Programme on Tuberculosis and Lung Health, creating a new structure -the Department of HIV, TB, Hepatitis and STIs.Although this decision was driven by unprecedented financial shortfalls, there is a strong underlying rationale, creating opportunities to identify synergies and efficiencies without losing the gains made in recent years.HIV, TB, Hepatitis and ST…
Public health (3 works) · Tuberculosis Research and Epidemiology (3 works) · Global health (2 works) · Medicine (2 works) · Tuberculosis (2 works) · Action (physics) (1 works) · Computer Science (1 works) · COVID-19 diagnosis using AI (1 works) · COVID-19 epidemiological studies (1 works) · Data-Driven Disease Surveillance (1 works)